16115-82-5 Usage
General Description
3-Amino-4-nitropyrazole is a chemical compound with the molecular formula C3H4N4O2. It is a yellow solid that is primarily used in the synthesis of various pharmaceuticals and agrochemicals. 3-Amino-4-nitropyrazole is also used as a building block in the synthesis of heterocyclic compounds and as a reagent in organic chemistry reactions. It is known for its high reactivity and is commonly handled and stored under strict laboratory conditions due to its potential hazards. 3-Amino-4-nitropyrazole is important in the field of medicinal chemistry and is used in the development of new drugs with various therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 16115-82-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,1,1 and 5 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 16115-82:
(7*1)+(6*6)+(5*1)+(4*1)+(3*5)+(2*8)+(1*2)=85
85 % 10 = 5
So 16115-82-5 is a valid CAS Registry Number.
InChI:InChI=1/C3H4N4O2/c4-3-2(7(8)9)1-5-6-3/h1H,(H3,4,5,6)
16115-82-5Relevant articles and documents
Nitropyrazoles 8. 3(5)-Amino-4-nitropyrazole: convenient synthesis and study of nitration
Shevelev, S. A.,Vinogradov, V. M.,Dalinger, I. L.,Cherkasova, T. I.
, p. 1861 - 1864 (1993)
A new preparative method for the synthesis of 3(5)-amino-4-nitropyrazole starting from accesible 3(5)-methylpyrazole has been elaborated.Nitration of the former affords 3(5)-nitramino-4-nitropyrazole or 1,4-dinitro-3-aminopyrazole, depending on the reaction conditions. - Key words: 3(5)-amino-4-nitropyrazole, aminonitropyrazoles, nitration.
PYRROLOPYRIMIDINE COMPOUNDS, USE AS INHIBITORS OF THE KINASE LRRK2, AND METHODS FOR PREPARATION THEREOF
-
Paragraph 00432, (2017/07/06)
The present disclosure is concerned with certain pyrrolopyrimidine compounds that are capable of inhibiting certain protein kinases, and especially the leucine-rich repeat kinase 2 (LRRK2) protein. Compounds of the present disclosure can be used to treat
